Xcout IntelC2N Diagnostics, LLC competitors & alternatives
The 12 closest competitors and alternatives to C2N Diagnostics, LLC — ranked by similarity to what C2N Diagnostics, LLC actually does, not by market-cap band.
Subscribe to see C2N Diagnostics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About C2N Diagnostics, LLC
C2N Diagnostics, LLC is a biotechnology company that develops blood-based diagnostic tests for neurodegenerative diseases, particularly Alzheimer’s disease. Its Precivity d tests use mass spectrometry-based plasma biomarkers and are intended for use by healthcare providers and researchers in evaluating patients for Alzheimer’s pathology.
C2N Diagnostics, LLC at a glance
C2N Diagnostics, LLC is a company headquartered in United States. Its most recent funding round, Debt, raised $20M in May 2026. Xcout tracks 10 named people at C2N Diagnostics, LLC, including Joel Braunstein (CEO).
C2N Diagnostics, LLC leadership
- Joel BraunsteinCEO
- Micah R. OnixtExecutive Vice President
- David HoltzmanScientific Co-Founder
- Randall BatemanScientific Co-Founder
- Dr. Joel BraunsteinExecutive Officer
- Micah OnixtExecutive Officer
4 more named people on record for C2N Diagnostics, LLC, with roles, board committees and tenure — see the full roster →
C2N Diagnostics, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $20M | 1 named | |
| SEC Form D filing | $10M | — | |
| Debt | $54M | 5 named | |
| SEC Form D filing | $25M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 C2N Diagnostics, LLC competitors
Ranked by semantic similarity — how close each company is to C2N Diagnostics, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Close match by what they do
NeuroQuest Development Center, Inc. is a biotechnology company that operates a development center located in North Charleston, South Carolina, and announced plans to begin US clinical validation trials for an Alzheimer's blood test.
Biotechnology
Veravas Inc. develops diagnostic technology and testing solutions, including its proprietary VeraBIND platform, designed to reduce laboratory test interference and detect hard-to-find biomarkers. The company primarily serves clinicians, researchers, and patients by providing tools and assays focused on the early detection of complex conditions such as Alzheimer's disease and other dementias.
Diagnostic Equipment
Brazos Neuroscience is a neurodiagnostics company delivering objective, blood-based biomarker testing to support neurological assessment and research. Based in Texas, the company focuses on advancing neuroscience through clinical innovation.
Diagnostics
i2Dx, Inc. is a US-based company founded in 2012 that develops a multimodal, cloud-based diagnostic platform. The platform is designed for the assessment and diagnosis of neurological disorders using quantitative digital assessments.
Life Sciences
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Biotechnology
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Biotechnology
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Biotechnology
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Healthcare & Life Sciences
Cognision is a biotechnology research company headquartered in Louisville, Kentucky (with primary offices also noted in Boston, Massachusetts). The firm develops advanced neurological assessment tools and diagnostic technologies.
Close match by what they do
NeuroDex Inc is a neurological biomarker company with corporate offices located in Massachusetts. The company specializes in neurological diagnostics and related biomarker research.
Close match by what they do
ALZpath, Inc. is a diagnostic company that specializes in blood test-based detection for Alzheimer's disease. The company is headquartered in Carlsbad, California, and employs between 11 and 50 people.
Diagnostics & Genetic Testing
Athena Diagnostics provides specialized diagnostic and genetic testing services focusing on neurological diseases, neuromuscular disorders, and developmental disorders such as Alzheimer's disease and muscular dystrophy. The company serves patients and healthcare providers by offering test catalogs, sample collection kits, requisition resources, and billing support.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of C2N Diagnostics, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for C2N Diagnostics, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →